|Bid||1.67 x 300|
|Ask||1.84 x 200|
|Day's Range||1.70 - 1.89|
|52 Week Range||0.83 - 4.75|
|PE Ratio (TTM)||0.31|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||19.00|
NEW YORK, July 19, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (SPEX), an intellectual property development company committed to fostering of technology and monetization of intellectual property, today announced that it has priced a firm commitment underwritten public offering of 1,250,000 shares of its common stock at a price to the public of $2.00 per share. In addition, Spherix has granted the underwriter a 45-day option to purchase up to 187,500 additional shares of common stock to cover over-allotments, if any.
Spherix Incorporated Acquires 6,800,000 shares of Hoth Therapeutics NEW YORK , July 3, 2017 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) reported today, following the disclosure made June 20 th ...
NEW YORK, June 27, 2017 /PRNewswire/ -- Spherix Incorporated (SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today issued a letter to shareholders. With that in mind, I'm going to provide you with more information on the transaction and update you on why we believe this transaction has positioned Spherix for growth. I want each of you to know that I see the fundamentals at Spherix stronger than at any time in the last few years and our path to value creation is moving forward with focus.